Alkem Laboratories to Invest ₹533 Crore in New Manufacturing Facility in Ujjain

Pharmaceutical company Alkem Laboratories Ltd has announced plans to establish a new formulations manufacturing facility in Ujjain, Madhya Pradesh. 

The company has received an allotment letter for ~30 acres of land in Phase 2 of the industrial area developed by DMIC Vikram Udyogpuri Ltd. The project represents a significant expansion of Alkem’s manufacturing capabilities and will be developed in phases.

Investment and Project Details

Alkem Laboratories’ board of directors has approved an investment of up to ₹533 crore for the greenfield project. The facility will be set up on the allotted land in the industrial area in Ujjain and will focus on manufacturing pharmaceutical formulations.

The investment is expected to strengthen the company’s production capacity and support its growth strategy in both domestic and international markets. The project will be implemented in multiple phases as the company gradually expands operations at the site.

Financial Performance Highlights

Alkem Laboratories reported steady financial performance in the December quarter. The company recorded a net profit of ₹626 crore, representing a 5% increase compared to ₹595 crore reported in the same quarter last year.

Revenue from operations stood at ₹3,374 crore during the quarter, reflecting a modest year-on-year growth of 1.5%. The company also reported growth in operating performance, with EBITDA rising 7.4% to ₹759 crore compared to ₹707.4 crore in the previous year.

Improvement in Profitability and Global Presence

The company’s EBITDA margin improved by 120 basis points to 22.5% during the quarter, compared with 21.3% in the year-ago period. For the first nine months of the financial year, EBITDA margin stood at 21.6%, exceeding the company’s earlier guidance.

International markets continue to contribute to Alkem’s overall performance. Sales from the United States accounted for 19.1% of total revenue during the quarter, while other international markets including Latin America, Australia and Europe contributed 9.8%.

Alkem Laboratories Share Price Today

On March 19, 2026, Alkem Laboratories share price (NSE: ALKEM) opened at ₹5,309.00, touching the day’s low at ₹5,232.00, as of 11:53 AM on the NSE.

Also Read: Alkem Laboratories - German Health Authority Issues EU GMP Certificate for Baddi Plant!

Conclusion

The proposed manufacturing facility in Ujjain marks an important step in Alkem Laboratories’ expansion plans. With continued investments in production capacity and a growing international presence, the company aims to strengthen its position in the global pharmaceutical industry while supporting long-term business growth.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.